Search research articles
Contact Us
Filters
Showing results (231-240 of 697) with videos related to
Page
of 70
Sort By:
JAMA
|
October 12, 2000
Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
D M Grabrick, L C Hartmann, J R Cerhan, et al.
Medicine
|
October 20, 2000
Association of Peutz-Jeghers-like mucocutaneous pigmentation with breast and gynecologic carcinomas in women
L A Boardman, M R Pittelkow, F J Couch, et al.
Cancer Medicine
|
August 30, 2022
Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration
Firat Kara, Christine M Lohse, Anna M Castillo, et al.
JAMA Oncology
|
May 27, 2021
Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States
Susan M Domchek, Song Yao, Fei Chen, et al.
Human Mutation
|
October 13, 2011
ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes
Amanda B Spurdle, Sue Healey, Andrew Devereau, et al.
Scientific Reports
|
September 28, 2022
Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay
Thales C Nepomuceno, Ana P P Dos Santos, Vanessa C Fernandes, et al.
Briefings in Bioinformatics
|
September 12, 2015
Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes
Steven N Hart, Kara N Maxwell, Tinu Thomas, et al.
Frontiers in Oncology
|
September 18, 2015
Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia
Jingying Xu, Ashley Sloane Margol, Anju Shukla, et al.
BMJ Open
|
October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
Thomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.
Gynecologic Oncology
|
June 2, 2026
Clinical relevance of transcriptome profiling for assessing prognosis, platinum insensitivity, and precision therapeutics in endometrial cancer
Jesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, et al.
Page
of 70
Search research articles
Search
Showing results (231-240 of 697) with videos related to
Sort By:
Page
of 70
JAMA
|
October 12, 2000
Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
D M Grabrick, L C Hartmann, J R Cerhan, et al.
Medicine
|
October 20, 2000
Association of Peutz-Jeghers-like mucocutaneous pigmentation with breast and gynecologic carcinomas in women
L A Boardman, M R Pittelkow, F J Couch, et al.
Cancer Medicine
|
August 30, 2022
Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration
Firat Kara, Christine M Lohse, Anna M Castillo, et al.
JAMA Oncology
|
May 27, 2021
Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States
Susan M Domchek, Song Yao, Fei Chen, et al.
Human Mutation
|
October 13, 2011
ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes
Amanda B Spurdle, Sue Healey, Andrew Devereau, et al.
Scientific Reports
|
September 28, 2022
Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay
Thales C Nepomuceno, Ana P P Dos Santos, Vanessa C Fernandes, et al.
Briefings in Bioinformatics
|
September 12, 2015
Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes
Steven N Hart, Kara N Maxwell, Tinu Thomas, et al.
Frontiers in Oncology
|
September 18, 2015
Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia
Jingying Xu, Ashley Sloane Margol, Anju Shukla, et al.
BMJ Open
|
October 27, 2021
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
Thomas E Rohan, Mindy Ginsberg, Yihong Wang, et al.
Gynecologic Oncology
|
June 2, 2026
Clinical relevance of transcriptome profiling for assessing prognosis, platinum insensitivity, and precision therapeutics in endometrial cancer
Jesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, et al.
Page
of 70